mSEPT9 has displayed efficacy as a plasma-based circulating biomarker for the detection of colorectal cancer, as SEPT9 production is regulated by epigenetic events which have proven critical in the initiation and progression of cancer (21, 22). This evidence concerns the gene SEPTIN9 and cancer.